2024 Q1 Form 10-Q Financial Statement

#000121390024091822 Filed on October 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $4.476K
YoY Change
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $4.476K
YoY Change -92.67%
Gross Profit Margin 100.0%
Selling, General & Admin $388.0K
YoY Change 220.25%
% of Gross Profit 8667.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $195.7K $387.9K
YoY Change -49.54% 220.25%
Operating Profit -$195.7K -$383.5K
YoY Change -48.95% 538.59%
Interest Expense $269.5K
YoY Change -385.76%
% of Operating Profit
Other Income/Expense, Net -$356.1K $1.001M
YoY Change -135.57% -15372.54%
Pretax Income -$551.9K $617.6K
YoY Change -189.35% -386.69%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$551.9K $617.6K
YoY Change -189.35% -386.69%
Net Earnings / Revenue 13798.97%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 109.5M shares 31.30B
Diluted Shares Outstanding 109.5M shares 28.16B

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $87.62K
YoY Change 3086.18%
Cash & Equivalents $2.009K $87.62K
Short-Term Investments
Other Short-Term Assets $860.00
YoY Change
Inventory
Prepaid Expenses
Receivables $18.17K $0.00
Other Receivables $0.00
Total Short-Term Assets $65.57K $88.47K
YoY Change -25.89% 3117.24%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $65.57K $88.47K
Total Long-Term Assets $0.00 $0.00
Total Assets $65.57K $88.47K
YoY Change -25.89% 3117.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.190M $952.9K
YoY Change 24.88% 191.93%
Accrued Expenses $13.50K $332.0K
YoY Change -95.93% -79.65%
Deferred Revenue
YoY Change
Short-Term Debt $607.2K
YoY Change -28.32%
Long-Term Debt Due $303.5K
YoY Change
Total Short-Term Liabilities $4.777M $4.645M
YoY Change 2.85% 54.1%
LONG-TERM LIABILITIES
Long-Term Debt $260.5K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $260.5K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.777M $4.645M
Total Long-Term Liabilities $260.5K
Total Liabilities $4.970M $4.906M
YoY Change 1.32% 62.74%
SHAREHOLDERS EQUITY
Retained Earnings -$13.54M -$8.626M
YoY Change 57.02%
Common Stock $1.096K $313.0K
YoY Change -99.65%
Preferred Stock
YoY Change
Treasury Stock (at cost) $773.5K $773.5K
YoY Change 0.0%
Treasury Stock Shares $2.917K
Shareholders Equity -$4.905M -$4.817M
YoY Change
Total Liabilities & Shareholders Equity $65.57K $88.47K
YoY Change -25.89% 3117.24%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$551.9K $617.6K
YoY Change -189.35% -386.69%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$84.30K -$79.49K
YoY Change 6.05% 2585.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $285.5K
YoY Change
Debt Paid & Issued, Net $220.5K
YoY Change
Cash From Financing Activities $80.00K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$84.30K -79.49K
Cash From Investing Activities
Cash From Financing Activities $80.00K 0.000
Net Change In Cash -$4.299K -79.49K
YoY Change -94.59%
FREE CASH FLOW
Cash From Operating Activities -$84.30K -$79.49K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-54624
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Bowmo, inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4144571
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
99 Wall Street
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 891
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York City
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10005
CY2024Q1 dei City Area Code
CityAreaCode
(212)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
398-0002
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock
CY2024Q1 dei Trading Symbol
TradingSymbol
BOMO
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
136458010 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2009 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6308 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18172 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18172 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45388 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1838 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
65569 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
26318 usd
CY2024Q1 us-gaap Assets
Assets
65569 usd
CY2023Q4 us-gaap Assets
Assets
26318 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1189952 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1144755 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13500 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
213696 usd
CY2024Q1 bomo Accrued Interest Current
AccruedInterestCurrent
364598 usd
CY2023Q4 bomo Accrued Interest Current
AccruedInterestCurrent
364598 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1509499 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1384499 usd
CY2024Q1 us-gaap Loans Payable Current
LoansPayableCurrent
30000 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
30000 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
189590 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
440109 usd
CY2024Q1 bomo Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
205684 usd
CY2023Q4 bomo Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
205684 usd
CY2024Q1 us-gaap Construction Payable Current
ConstructionPayableCurrent
200000 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
819944 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
433818 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4777267 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4471659 usd
CY2024Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
193202 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
193202 usd
CY2024Q1 us-gaap Liabilities
Liabilities
4970469 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4664861 usd
CY2024Q1 bomo Treasury Stock Share
TreasuryStockShare
2917 shares
CY2023Q4 bomo Treasury Stock Share
TreasuryStockShare
2917 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
773500 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
773500 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13544752 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12992877 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-4904900 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4638533 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65569 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26318 usd
CY2023Q1 us-gaap Revenues
Revenues
4476 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
4476 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
121314 usd
CY2023Q1 bomo Consulting Expense
ConsultingExpense
30000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
39500 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
160054 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31249 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76581 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
195749 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
387949 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-195749 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-383473 usd
CY2023Q1 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
269500 usd
CY2023Q1 bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
32429 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
356126 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1303044 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-356126 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1001115 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-551875 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
617642 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-551875 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
617642 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5896662 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
617642 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5279020 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4638533 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
285508 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-551875 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-4904900 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-551875 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
617642 usd
CY2024Q1 bomo Interest Expense Incurred On Put Premium On Stock Settled Debt
InterestExpenseIncurredOnPutPremiumOnStockSettledDebt
-30000 usd
CY2023Q1 bomo Interest Expense Incurred On Put Premium On Stock Settled Debt
InterestExpenseIncurredOnPutPremiumOnStockSettledDebt
30000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
245146 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
96314 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-17.075 usd
CY2023Q1 bomo Initial Derivative Expense
InitialDerivativeExpense
-32.429 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
356126 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1303044 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15542 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
43550 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
60197 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
138972 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-200197 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-286 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-8127 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
125000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
38850 usd
CY2024Q1 bomo Increase Decrease In Acquisitionpayable
IncreaseDecreaseInAcquisitionpayable
200000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-84299 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79487 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
285518 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
220518 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4299 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79487 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6308 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167103 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2009 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87616 usd
CY2024Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
285518 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">NOTE 1 – BACKGROUND</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Reverse Merger and Corporate Restructure</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 4, 2022, Cruzani, Inc. (“Cruzani” or the “Predecessor”) entered into a merger agreement (the “Merger Agreement”) with Bowmo, Inc. (“Bowmo”) and Bowmo Merger Sub, Inc. to acquire Bowmo. (the “Acquisition”). The transactions contemplated by the Merger Agreement were consummated on May 4, 2022, and pursuant to the terms of the Merger Agreement, all outstanding shares of Bowmo were exchanged for shares of Cruzani’s common stock and Bowmo became Cruzani’s wholly owned subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The merger was effected pursuant to the Merger Agreement. The merger is being accounted for as a reverse merger whereby Bowmo is the acquirer for accounting purposes. Bowmo is considered the acquiring company for accounting purposes as upon completion of the Merger, Bowmo’s former stockholders held a majority of the voting interest of the combined company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the merger, the Company issued Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders. Upon completion of the acquisition, Bowmo is treated as the surviving entity and accounting acquirer although Cruzani was the legal acquirer. Accordingly, the historical financial statements are those of Bowmo.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Accounting for Reverse Merger</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of Cruzani assets acquired and liabilities assumed was based upon management’s estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the allocation of purchase price of the acquisition: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; font-style: italic">Tangible Assets Acquired:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Allocation</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">517</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(326,400</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,197,027</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued officer compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(453,333</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Convertible Notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(620,933</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Put premium on stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(230,743</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Loans payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(254,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net Tangible Assets Acquired</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(3,082,419</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left">Equity Acquired:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(33,815</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(50,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series E Preferred stock to be issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(166,331</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Common stock 20,000,000,000 shares authorized, $0.00001 par value; 8,955,014,498 shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(89,550</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Treasury stock, at cost – 2,917 shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">773,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additional paid in capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,648,676</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic">Consideration:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Organization and Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bowmo, Inc. (FKA Cruzani, Inc.) (the “Company”) is an AI-powered recruiting platform. The Company’s principal lines of business are direct placement of candidates with employers and Recruiting as a Service which allows the Company’s customers to outsource the management of their recruiting process to the Company. The Company offers recruiting software and services through an online AI-driven platform to connect potential candidates to employers for all businesses looking to address hiring needs. The Company was incorporated as a Delaware corporation in 2016.</p>
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-551875 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-195749 usd
CY2024Q1 bomo Working Capital Deficit
WorkingCapitalDeficit
4711698 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13544752 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</p>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2009 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87616 usd
CY2023 us-gaap Revenues
Revenues
243434 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentrations of credit risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments which potentially subject the Company to credit risks consist primarily of cash and cash equivalents, and accounts receivable. Cash and cash equivalents are held in United States financial institutions. At times such amounts may exceed federally insured limits.</p>
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
58092 usd
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
198982 usd
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
216367 usd
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4595717 usd
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-287779 usd
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.02
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Loans Payable
LoansPayable
269500 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
254500 usd
CY2024Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
426160 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
646679 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
236570 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
206570 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
189590 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
440109 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
30000 usd
CY2024Q1 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
12 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
10000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
10000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
10000 usd
CY2024Q1 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.10 pure
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
331600 usd
CY2021Q4 us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.10 pure
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
11000 usd
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
6728 usd
CY2023 bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
0 usd
CY2022 bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
27856 usd
CY2021Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
110992 usd
CY2022 bomo Change Due To Issuances
ChangeDueToIssuances
-2718645 usd
CY2022 bomo Derivative Liability Transfer To Put Premium
DerivativeLiabilityTransferToPutPremium
-112537 usd
CY2022 bomo Derivative Gain Loss On Derivative Fair Value
DerivativeGainLossOnDerivativeFairValue
-544850 usd
CY2022Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
2172250 usd
CY2023 bomo Change Due To Issuances
ChangeDueToIssuances
4035300 usd
CY2023 bomo Derivative Liability Transfer To Put Premium
DerivativeLiabilityTransferToPutPremium
651156 usd
CY2023 bomo Derivative Gain Loss On Derivative Fair Value
DerivativeGainLossOnDerivativeFairValue
1645712 usd
CY2023Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
433818 usd
CY2024Q1 bomo Derivative Gain Loss On Derivative Fair Value
DerivativeGainLossOnDerivativeFairValue
386126 usd
CY2024Q1 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
819944 usd
CY2024Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9693 usd
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
38771 usd
CY2019Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
10000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022 bomo Stock Issued During Period Extinguishment Of Convertible Debt
StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt
18094721962 usd
CY2023 bomo Stock Issued During Period Extinguishment Of Convertible Debt
StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt
6364768689 usd
CY2024Q1 bomo Stock Issued During Period Extinguishment Of Convertible Debt
StockIssuedDuringPeriodExtinguishmentOfConvertibleDebt
56020716 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109541546 shares
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.025
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
0.001
CY2023Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
38800000 shares
CY2023 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y6M21D
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.001
CY2024Q1 bomo Increased Decrease Indebtedness
IncreasedDecreaseIndebtedness
1200000 usd
CY2017Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
27084 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12992877 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9243925 usd
CY2024Q1 bomo Percentage Of Annual Utilization Of Current Year Income Percentage
PercentageOfAnnualUtilizationOfCurrentYearIncomePercentage
0.80 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3361000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2923000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
517618 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
245000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
192697 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
193000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4017315 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3361000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4017315 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3361000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.1529 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.1529 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.025 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.025 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3879 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3879 pure
CY2024Q1 bomo Percentage Of Minimum Change In Ownership
PercentageOfMinimumChangeInOwnership
0.50 pure
CY2020Q1 bomo Coronavirus Aid Relief And Economic Security Act Relief Package Amount
CoronavirusAidReliefAndEconomicSecurityActReliefPackageAmount
2000000000000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
710315 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1777000 usd
CY2024Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2024Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Revenues
Revenues
usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
usd
CY2024Q1 bomo Consulting Expense
ConsultingExpense
usd
CY2024Q1 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2024Q1 bomo Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
usd
CY2024Q1 bomo Initial Recognition Of Derivative Liability
InitialRecognitionOfDerivativeLiability
usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2024Q1 bomo Initial Derivative Expense
InitialDerivativeExpense
usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CY2023Q1 bomo Increase Decrease In Acquisitionpayable
IncreaseDecreaseInAcquisitionpayable
usd
CY2024Q1 bomo Cash Acquired In Reverse Merger
CashAcquiredInReverseMerger
usd
CY2023Q1 bomo Cash Acquired In Reverse Merger
CashAcquiredInReverseMerger
usd
CY2024Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
CY2023Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q1 us-gaap Revenues
Revenues
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
CY2022 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001381871

Files In Submission

Name View Source Status
0001213900-24-091822-index-headers.html Edgar Link pending
0001213900-24-091822-index.html Edgar Link pending
0001213900-24-091822.txt Edgar Link pending
0001213900-24-091822-xbrl.zip Edgar Link pending
bomo-20240331.xsd Edgar Link pending
bomo-20240331_cal.xml Edgar Link unprocessable
ea0217573-10q_bowmo.htm Edgar Link pending
ea0217573ex31-1_bowmo.htm Edgar Link pending
ea0217573ex32-1_bowmo.htm Edgar Link pending
ex31-1_01.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
bomo-20240331_lab.xml Edgar Link unprocessable
bomo-20240331_def.xml Edgar Link unprocessable
bomo-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0217573-10q_bowmo_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending